Parcion Private Wealth’s Fate Therapeutics FATE Stock Holding History

Parcion Private Wealth’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.2K	Buy	21,555 +5,087	+31%	+$9.41K	﹤0.01%	515
2026 Q1	$19.8K	Buy	16,468 +2,411	+17%	+$2.94K	﹤0.01%	432
2025 Q4	$13.8K	Sell	14,057 -412	-3%	-$495	﹤0.01%	420
2025 Q3	$18.2K	Sell	14,469 -16,316	-53%	-$17.6K	﹤0.01%	356
2025 Q2	$34.5K	Buy	30,785 +392	+1%	+$456	﹤0.01%	298
2025 Q1	$24K	Buy	30,393 +2,393	+9%	+$2.93K	﹤0.01%	287
2024 Q4	$46.2K	Hold	28,000	–	–	﹤0.01%	240
2024 Q3	$98K	Hold	28,000	–	–	0.01%	235
2024 Q2	$91.8K	Hold	28,000	–	–	0.01%	194
2024 Q1	$206K	Hold	28,000	–	–	0.02%	188
2023 Q4	$105K	Hold	28,000	–	–	0.01%	187
2023 Q3	$59.4K	Hold	28,000	–	–	0.01%	182
2023 Q2	$133K	Hold	28,000	–	–	0.01%	179
2023 Q1	$160K	Hold	28,000	–	–	0.02%	180
2022 Q4	$283K	Hold	28,000	–	–	0.03%	167
2022 Q3	$627K	Hold	28,000	–	–	0.07%	133
2022 Q2	$869K	Hold	28,000	–	–	0.09%	131
2022 Q1	$1.09M	Hold	28,000	–	–	0.1%	106
2021 Q4	$1.21M	Hold	28,000	–	–	0.11%	101
2021 Q3	$1.72M	Hold	28,000	–	–	0.15%	98
2021 Q2	$2.43M	Hold	28,000	–	–	0.24%	86
2021 Q1	$2.31M	Hold	28,000	–	–	0.26%	86
2020 Q4	$2.55M	Hold	28,000	–	–	0.34%	63
2020 Q3	$1.07M	Hold	28,000	–	–	0.16%	93
2020 Q2	$1.03M	Hold	28,000	–	–	0.17%	87
2020 Q1	$622K	Buy	+28,000	New	+$708K	0.17%	87

Other funds holding FATE

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parcion Private Wealth's FATE Position: Q2 2026 in Review

Parcion Private Wealth increased its Fate Therapeutics (FATE) stake by 31% in Q2 2026, buying an estimated $9.41K and bringing the position to 21,555 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Parcion Private Wealth first reported a position in FATE in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.55M in Q4 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

Parcion Private Wealth held 21,555 shares of Fate Therapeutics worth $58.2K as of Q2 2026.
Parcion Private Wealth bought 5,087 Fate Therapeutics shares in Q2 2026, an estimated $9.41K.
Fate Therapeutics made up ﹤0.01% of Parcion Private Wealth's portfolio in Q2 2026, its #515 holding.
Parcion Private Wealth first reported a position in Fate Therapeutics in Q1 2020 and has held it in 26 quarters since.
Parcion Private Wealth's Fate Therapeutics position peaked at $2.55M in Q4 2020.
156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.